Browsing “Pricentric One Blog | EVERSANA”

Pricentric Insights: What a Biden Presidency Could Mean for Drug Pricing in the U.S.

Country: UNITED STATES | Region: NORTH AMERICA | Type: Policy | Keywords: #biden #debate #donald #drug #harris #joe #kamala #policy #presidency #pricing #states #trump #united PRICENTRIC BRIEF: With the final presidential debate looming tonight, October 22, and Election Day two weeks away, Democratic presidential nominee Joe Biden’s drug pricing proposals hang primarily on one overarching […]

UK’s MHRA Joins ACSS-Consortium, FDA’s Project Orbis

Country: AUSTRALIA, CANADA-ONTARIO, SINGAPORE, SWITZERLAND, UNITED KINGDOM, UNITED STATES | Region: ASIA & SOUTH PACIFIC, EUROPE, NORTH AMERICA, SOUTH AMERICA | Type: Regulation | Keywords: #acssconsortium #anvisa #concurrentsubmission #fda #healthcanada #hsa #hta #mhra #projectorbis #swissmedic #tga PRICENTRIC BRIEF: The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) is officially joining the Australia-Canada-Singapore-Switzerland (ACSS) Consortium on January 1, 2021, after first shadowing the Consortium As noted by MHRA, “The addition of the UK brings the combined population of countries participating in the […]

Japan’s Ministry of Health Proposes Finalized Off-Year Re-pricing for All Medicines

Country: JAPAN | Region: ASIA & SOUTH PACIFIC | Type: Pricing & Reimbursement | Keywords: #cost #generics #japan #medicines #mof #moh #nhi #off #patented #pricing #revision #sakigake PRICENTRIC BRIEF: Japan’s Ministry of Finance (MOF) has presented its proposal on the country’s planned off-year drug re-pricing, and called for a total revision of all products including patent-protected medicines, in order to reduce the financial […]

EMA Commences Rolling Review of Second COVID-19 Vaccine

 Country: NETHERLANDS | Region: EU28, EUROPE | Type: Regulation | Keywords: #biontech #chmp #covid19 #ema #pfizer #rollingreview #vaccine PRICENTRIC BRIEF: The European Medicines Agency’s (EMA) human medicines committee (CHMP) has commenced a rolling review of data for Pfizer and BioNTech’s potential COVID-19 vaccine candidate, BNT162b2 CHMP’s decision to start the rolling review of BNT162b2 is based on promising preliminary results from non-clinical trials and early clinical studies, in which it has […]

California to Produce Own Generics to Lower Prescription Drug Costs

Country: UNITED STATES | Region: NORTH AMERICA | Type: Policy | Keywords: #calrx #essentialmedicines #generics #hhs #prescriptiondrugs #sb852 #statedruglabel PRICENTRIC BRIEF: California Governor Gavin Newsom has signed legislation aimed at bringing down the cost of prescription drugs for taxpayers, employers, and consumers in California by teaming up with manufacturers to produce and distribute generic prescription drugs Under SB 852, California will create Cal Rx, […]

PPMA 2020 Insights: Trends in HTA Decisions

Country: THE NETHERLANDS | Region: EUROPE | Type: PPMA 2020 Insights PRICENTRIC BRIEF: At PPMA 2020, EVERSANA’s Dr. Magdi Stino and Alan Crowther came together to detail some recent trends and share approaches for using Health Technology Assessment (HTA) data when decision making, leveraging information from the Pricentric HTA database   Looking specifically at the UK, Germany, France, Canada, and Brazil, Dr. Stino went on to assess the recommendation types for all […]

Switzerland’s Journey to Introducing Confidential Managed-Entry Agreements

Country: SWITZERLAND | Region: EUROPE | Type: Policy PRICENTRIC BRIEF: Switzerland’s Ministry of the Interior has introduced a new law, dubbed “Modèles de Prix Pour Médicaments”, which aims to establish a legal basis for the use of confidential market-access schemes to improve patient access to innovative medicines It is also introducing cost-containment measures for the compulsory health insurance scheme (AOS), dictating, for […]

German Payer GKV-SV Concerned Over Added Value of Health Apps

Country: GERMANY | Region: EUROPE | Type: Pricing & Reimbursement | Keywords: #amnog #bfarm #digitalsupplyact #gkvsv #gsv #healthapps #hta #regulation PRICENTRIC BRIEF: While Germany’s umbrella payer, GKV-Spitzenverband (GKV-SV) sees great potential in funding digital health applications, legal funding regulations are a “major problem,” said GKV-SV Board Member, Stefanie Stoff-Ahnis Security, function, quality, data protection and data security of the apps will undergo tests by the Federal Institute for Drugs and Medical […]

FDA Approves Roche’s HIV Qualitative Test

Country: UNITED STATES | Region: NORTH AMERICA | Type: Drug Approval | Keywords: #cobas #fda #hiv #hiv-1 #hiv-2 #qualitative #roche #test PRICENTRIC BRIEF: Roche announced the U.S. Food and Drug Administration (FDA) approval for the cobas HIV-1/HIV-2 Qualitative Test for use on the fully automated cobas 6800/8800 Systems in the U.S. The test provides healthcare professionals with a single result to confirm HIV diagnosis and differentiate HIV-1 and HIV-2, an important […]

Just Half of Germany’s Clinical Cancer Registries Fully Operational at the End of Last Year

Country: GERMANY | Region: EUROPE | Type: Policy | Keywords: #cancer #germany #gkv-sv #insurance #operational #registry PRICENTRIC BRIEF: The National Association of Statutory Health Insurance Funds, GKV-Spitzenverband (GKV-SV), has noted that at the end of 2019, just under half of Germany’s clinical cancer registries were fully operational At the cut-off, December 31, the group says that just four – Baden-Württemberg, Bremen, Rhineland-Palatinate, Saarland – met eligibility criteria for the health insurances […]